Omada Health, Inc. (NASDAQ:OMDA) Receives $22.91 Consensus Target Price from Analysts

Shares of Omada Health, Inc. (NASDAQ:OMDA) have been assigned an average recommendation of “Moderate Buy” from the thirteen brokerages that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have given a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $22.9091.

A number of research firms have issued reports on OMDA. Citigroup reiterated an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Barclays increased their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. JPMorgan Chase & Co. reduced their target price on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a report on Thursday, March 12th. The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a report on Friday, May 8th. Finally, Evercore reiterated an “outperform” rating and set a $20.00 target price on shares of Omada Health in a report on Friday, May 8th.

Insiders Place Their Bets

In other Omada Health news, President Wei-Li Shao sold 2,829 shares of the stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $12.71, for a total transaction of $35,956.59. Following the sale, the president directly owned 328,850 shares in the company, valued at $4,179,683.50. This represents a 0.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Steven L. Cook sold 1,884 shares of the stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $13.94, for a total transaction of $26,262.96. Following the completion of the sale, the chief financial officer directly owned 200,512 shares in the company, valued at approximately $2,795,137.28. This represents a 0.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 8,776 shares of company stock worth $120,483 in the last ninety days. 6.38% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Omada Health

Large investors have recently modified their holdings of the company. Quarry LP purchased a new stake in shares of Omada Health in the 4th quarter valued at approximately $29,000. TD Waterhouse Canada Inc. purchased a new stake in shares of Omada Health in the 4th quarter valued at approximately $32,000. Raymond James Financial Inc. purchased a new stake in shares of Omada Health in the 2nd quarter valued at approximately $32,000. Strs Ohio purchased a new stake in shares of Omada Health in the 3rd quarter valued at approximately $38,000. Finally, Inlight Wealth Management LLC purchased a new stake in shares of Omada Health in the 4th quarter valued at approximately $45,000.

Omada Health Stock Performance

Shares of OMDA stock opened at $16.10 on Friday. The firm’s 50 day moving average price is $14.22 and its 200-day moving average price is $15.01. Omada Health has a one year low of $10.28 and a one year high of $28.40. The firm has a market cap of $957.15 million and a P/E ratio of -59.63.

Omada Health (NASDAQ:OMDA) last released its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million for the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. As a group, research analysts predict that Omada Health will post -0.04 EPS for the current fiscal year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.